Waldencast plc (WALD)

NASDAQ: WALD · Real-Time Price · USD
1.790
-0.010 (-0.56%)
At close: Feb 13, 2026, 4:00 PM EST
1.800
+0.010 (0.56%)
After-hours: Feb 13, 2026, 4:10 PM EST
Market Cap231.10M -38.8%
Revenue (ttm)274.56M +14.2%
Net Income-201.81M
EPS-1.79
Shares Out 128.39M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume43,316
Open1.820
Previous Close1.800
Day's Range1.730 - 1.820
52-Week Range1.450 - 3.540
Beta-0.47
AnalystsStrong Buy
Price Target4.30 (+140.22%)
Earnings DateNov 24, 2025

About WALD

Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand. The company operates through two segments, Obagi Medical and Milk Makeup. It offers skin care products to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and protect and enhance skin tone and texture; cosmetics; and other beauty products. In addition, the company provides foundation, concealer, primer, blush, setting spray, and bronzer categories, as w... [Read more]

Sector Financials
IPO Date Mar 16, 2021
Employees 335
Stock Exchange NASDAQ
Ticker Symbol WALD
Full Company Profile

Analyst Summary

According to 5 analysts, the average rating for WALD stock is "Strong Buy." The 12-month stock price target is $4.3, which is an increase of 140.22% from the latest price.

Price Target
$4.3
(140.22% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Obagi Medical and DermFx Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

DermFx selected as a leading regional med spa partner due to its commitment to exceptional patient care, aesthetic innovation, and excellence across Southern California practices DermFx selected as a ...

9 days ago - GlobeNewsWire

Obagi Medical and Moxie Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

Moxie selected as a leading aesthetic practice software and support partner for its commitment to innovation, compliance, and empowering aesthetic entrepreneurs Moxie selected as a leading aesthetic p...

10 days ago - GlobeNewsWire

Obagi Medical Introduces New Lip Therapy Protocol Designed to Resurface, Replenish, and Protect

The dermatologist-tested duo pairs gentle chemical resurfacing with daily hydration and SPF protection for visibly smoother lips The dermatologist-tested duo pairs gentle chemical resurfacing with dai...

12 days ago - GlobeNewsWire

Obagi Medical and VIO Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

VIO Med Spa selected as a key med spa franchise partner for its commitment to clinical excellence, innovation, and nationwide scalable aesthetic care VIO Med Spa selected as a key med spa franchise pa...

16 days ago - GlobeNewsWire

Obagi Medical and Next Health Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

Next Health selected as a leading wellness and longevity partner given its innovative approach to personalized aesthetics and health optimization Next Health selected as a leading wellness and longevi...

18 days ago - GlobeNewsWire

UPDATE - Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™

Alpha selected as the first Medspa platform partner given their commitment to innovation, education, and breaking through barriers Alpha selected as the first Medspa platform partner given their commi...

19 days ago - GlobeNewsWire

Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™

Alpha selected as the first Medspa platform partner given their commitment to innovation, education, and breaking through barriers Alpha selected as the first Medspa platform partner given their commi...

19 days ago - GlobeNewsWire

CORRECTION – Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

Platinum selected as the first dermatology platform partner due to its commitment to clinical evidence and dissemination across its network of practices Platinum selected as the first dermatology plat...

20 days ago - GlobeNewsWire

Obagi Medical Unveils ALOHA Program to Launch Obagi® saypha® MagIQ™ – Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler

Program Designed to Drive Real World, Practice Focused Evidence with Injectables & Skincare Program Designed to Drive Real World, Practice Focused Evidence with Injectables & Skincare

25 days ago - GlobeNewsWire

Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting

Obagi® saypha® ChIQ™ data selected as a top 10 cosmetic oral abstract presentation Obagi® saypha® ChIQ™ data selected as a top 10 cosmetic oral abstract presentation

3 months ago - GlobeNewsWire

Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilities

NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced that it had sold its righ...

3 months ago - GlobeNewsWire

Waldencast plc Provides Information Regarding Upcoming Earnings Release Dates

First Half Fiscal 2025 Results and Q3 2025 Financial Results Expected to be Reported on November 24, 2025 First Half Fiscal 2025 Results and Q3 2025 Financial Results Expected to be Reported on Novemb...

3 months ago - GlobeNewsWire

Obagi Medical Launches Nu-Cil® BioStim™ Scalp Serum

A Next-Generation, Redensifying Scalp Serum Clinically Proven to Promote Fuller, Denser-Looking Hair* A Next-Generation, Redensifying Scalp Serum Clinically Proven to Promote Fuller, Denser-Looking Ha...

4 months ago - GlobeNewsWire

Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand

U.S. Launch Planned in 2026 and Positions Obagi Medical as a Leading Dermatological Megabrand at the Convergence of Integrated Skincare and Aesthetics While Doubling its Addressable Market U.S. Launch...

5 months ago - GlobeNewsWire

Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation

Obagi Medical delivers H1 2025 double-digit growth in its Core Strategic Channels. Novaestiq Acquisition Doubles the Brand's Addressable Market in the U.S.

6 months ago - GlobeNewsWire

Waldencast Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Waldencast plc WALD will release earnings results for the second quarter after the closing bell on Monday, Aug. 18.

6 months ago - Benzinga

Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand

Acquisition strengthens Obagi Medical's product portfolio with proven, scientifically backed, injectable portfolio New products position Obagi Medical at the forefront of health, beauty and aesthetics...

7 months ago - GlobeNewsWire

Waldencast: Learning To Grow Hurts Sometimes

Waldencast is a fast-growing beauty company with strong brands (Milk Makeup, Obagi), but faces margin pressure and negative earnings due to high SG&A and debt. Recent revenue growth remains solid, but...

9 months ago - Seeking Alpha

Waldencast plc (WALD) Q1 2025 Earnings Call Transcript

Waldencast plc (NASDAQ:WALD) Q1 2025 Earnings Conference Call May 14, 2025 8:30 AM ET Company Participants Allison Malkin - Partner ICR, Investor Relations Michel Brousset - Founder & Chief Executive...

9 months ago - Seeking Alpha

Waldencast Reports Q1 2025 Financial Results

Q1 Net Revenue of $65.4 million, (4.1)% decline from Q1 202476.4% Adjusted Gross Margin, an improvement of 10 basis points$4.4 million of Adjusted EBITDA

9 months ago - GlobeNewsWire

Waldencast plc Announces First Quarter Fiscal 2025 Results Conference Call and Webcast

LONDON, May 06, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform provided the details for its First Quarter Fiscal 2025 confere...

10 months ago - GlobeNewsWire

Obagi Medical Announces the Launch of Retinol + PHA Refining Night Cream

A Scientific Breakthrough in Skin Renewal: A Clinically Proven Dual-Action, Slow-Release, Overnight Skin Renewal Cream for a Resurfaced, Smoother, and More Even-Looking Complexion

10 months ago - GlobeNewsWire

Waldencast plc (WALD) Q4 2024 Earnings Call Transcript

Waldencast plc (NASDAQ:WALD) Q4 2024 Earnings Conference Call March 19, 2025 8:30 AM ET Company Participants Allison Malkin - Investor Relations Michel Brousset - Founder and Chief Executive Officer ...

11 months ago - Seeking Alpha

Waldencast Reports Q4 2024 and Fiscal Year 2024 Financial Results

Q4 Net Revenue of $72.1 million, 29.4% Comparable Net Revenue Growth and $11.2 million of Adjusted EBITDA, doubling from Q4 2023

11 months ago - GlobeNewsWire

Waldencast plc Announces Fourth Quarter and Fiscal Year 2024 Results Conference Call and Webcast

LONDON, March 11, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform provided the details for its Fourth Quarter and Fiscal Year ...

1 year ago - GlobeNewsWire